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Background. Osteoarthritis (OA) is themost commonmusculoskeletal disease in the world. OA is the result of an inflammatory and
degenerative process affecting the entire joint. Osteoarthritis, especially involving the knee, has a relevant socioeconomic impact
in terms of drugs, hospital admissions, work absences, and temporary or permanent invalidity. Therapy of knee osteoarthritis
is based on pharmacological and nonpharmacological measures. Methods. We conducted a systematic review of the studies
published between 2002 and 2017 on spa therapy, mud-pack therapy, balneotherapy, and mud-bath therapy in the treatment of
knee osteoarthritis in order to investigate the evidence of the efficacy of such treatment on pain, functional limitation, drug use,
and quality of life. Overall, 35 studies were examined among which 12 were selected and included in the review if they are trial
comparative. We have been able to illustrate the main results obtained in the individual studies and to elaborate these results in
order to allow as much a unitary presentation as possible and hence an overall judgment. Results. Because the studies we reviewed
differedmarkedly fromone another in terms of themethods used, wewere unable to conduct a quantitative analysis (meta-analysis)
of pooled data from the 12 studies. For the purposes of the present review, we reevaluated the results of the different studies using
the same statistical method, Student’s t-test, which is used to compare the means of two frequency distributions. Among all the
studies, the most relevant indexes used to measure effectiveness of spa therapy were improved including VAS, Lequesne, and
WOMAC Score. Conclusions.Themud-pack therapy, balneotherapy, mud-bath therapy, and spa therapy have proved to be effective
in the treatment and in the secondary prevention of knee osteoarthritis, by reducing pain, nonsteroidal anti-inflammatory drug
consumption, and functional limitation and improving quality of life of affected patients.
1. Introduction
Osteoarthritis (OA) is the most common musculoskeletal
disease in the world, especially in the elderly; nonetheless
it should not be considered exclusively an aging disease. It
affects approximately 10% of people over 60 years old with a
significant impact on the quality of life of patients who are
limited in carrying out normal daily activities and on the
healthcare systems [1–3].
In Italy, rheumatic and musculoskeletal diseases (RMDs)
are the secondmost common chronic condition in the popu-
lation, and among themOA is themost frequent representing
themain cause of people’s disability [4].The prevalence ofOA
varies according to the definition of OA, the specific joint(s)
under study, and the characteristics of the study population
[3].
According to ISTAT data, osteoarthritis affects 15.9%
of the population; the prevalence is age-increasing and
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sex-dependent, being higher in women [5]. Symptomatic
OA is generally defined by the presence of pain, aching,
or stiffness in a joint with radiographic. On the basis of
a survey conducted in northwest Italy, 27% of the general
population (31,2% women and 22,1% men) were affected by
joint pain, defined by any pain lasting more than four weeks
[6]. OA was defined as an articular disease resulting from
loss of cartilage integrity in association with modifications
of the adjoining bone tissue, due to an imbalance between
catabolic phenomena and chondrocytic repair phenomena
[7]. Osteoarthritis is low-grade inflammatory disease of
synovial joints and is now defined as “a disorder involving
movable joints characterized by cell stress and extracellular
matrix degradation initiated by micro- and macro-injury
that activates maladaptive repair responses including pro-
inflammatory pathways of innate immunity. The disease
manifests first as a molecular derangement (abnormal joint
tissue metabolism) followed by anatomic, and/or physiologic
derangements (characterized by cartilage degradation, bone
remodeling, osteophyte formation, joint inflammation and
loss of normal joint function), that can culminate in illness.”
Inflammatory flaresmay be associatedwith swelling, redness,
and pain [8, 9]. Indeed, synovitis, which is secondary to
metabolic, biochemical, and mechanical alterations, is of
importance in its pathogenesis. For the purposes of classifi-
cation, it should be specified whether the knee osteoarthritis
is of unknown origin (idiopathic, primary) or is related to
a known medical condition or event (secondary). Clinical
criteria for the classification of idiopathicOAof the kneewere
developed through amulticenter study group [10]. Regarding
the prevalence of symptomatic knee OA in Italy, it ranges
from 5.39% to 29.8% with an age-increasing incidence from
27% of subjects under the age of 70 to 44% of patients
over 80 years of age. Moreover, women are more affected
than men (11% versus 7%) [6, 11, 12]. OA, particularly knee
osteoarthritis, has a high socioeconomic impact in terms of
drug spending, hospital admissions, work productivity, and
temporary or permanent incapacity [13, 14]. Treatment of
OA is based on pharmacological and nonpharmacological
measures [15]. The latter include the use of spa therapy
(in a broad sense, balneotherapy and/or mud-pack therapy)
integrated or alternated with other therapeutic prescriptions.
Also, spa therapy (multiple interventions in spa resorts and
in particular of mud-bath therapy) can be considered a cost-
saving measure in the management of knee OA [16, 17]. Mud
is a heated slurry, which is the result of the combination
of solid material (mainly clay) and mineral water, used for
external application after an adequate maturation period,
at a temperature between 45∘C and 50∘C for the duration
of 20-30 minutes. The baths consist of diving a patient in
a bathtub with thermal (with a temperature of 36–38∘C)
and mineral (with high mineral content) water for 20min.
The spa therapy comprises a broad spectrum of therapeutic
modalities includingmud-pack therapy, balneotherapy,mud-
bath therapy, hot showers, massage, and supervised water
exercises in spa resorts, adding other benefits as a pleasant
climate, relaxing natural scenery, and clean air [18]. The
objective of this review is to summarize the currently avail-
able information on clinical effects and briefly discuss the
possible mechanisms of action of spa therapy in knee OA.
2. Methods
We conducted a systematic review of the literature on spa
therapy in the treatment of knee osteoarthritis in order to
investigate the evidence of the efficacy of this treatment.
We searched MEDLINE via PubMed for articles published
between 2002 and 2017 using the terms “osteoarthritis”,
“knee osteoarthritis”, “SPA therapy”, “mud-bath therapy”,
and “randomized controlled clinical trials”. Studies were
included in this review if in accordance with the eligibil-
ity criteria: clinical trials with patients conforming to the
American College of Rheumatology (ACR) criteria relating
to kneeOA [10]; randomized controlled clinical trials (RCTs);
clinical trials whose the main objective was the effectiveness
of spa therapy [10]. The studies that were excluded from the
review were those that analyzed the effects of spa therapy in
different joints other than the knee, reviews, and those that
are not in English and not on clinical effect of spa therapy,
bath therapy, mud-pack therapy, and mud-bath therapy;
moreover the studies in which data are expressed as median,
with percentage but without absolute values or only with
a graphic representation, were excluded. Overall, 35 studies
were examined among which 12 were selected and included
in the review if they were trial comparative. The Study Flow
Diagram according to the Prisma Statement is reported in
Figure 1 [19].
Each report was reviewed to identify the criteria used for
study enrolment and for assignment to experimental versus
control groups, sample size, type and characteristics of treat-
ment, features of mineral water, control intervention, assess-
ment point, endpoints, outcome measures, and tests used for
statistical analysis of the results. Instead, data from each study
were critically analyzed and the main findings compared
with those of the other studies. For the quality assessment
of the studies that were included in the review after the
preliminary selection we considered the scientific value of
the international journals that published these researches,
the number of patients included in the studies, the methods
used to study the patients, and the possibility of exclusion
of more frequent studies bias. Moreover, we cannot exclude
the existence of publication bias that can occur for any
scientific research especially if related to topics concerning
therapeutic methods.
Of 12 studies included in the review, 5 were carried out
in Italy: 2 in Chianciano SPA (Siena) [20, 21], 2 in Rapolano
SPA (Siena) [22, 23], and 1 in Levico SPA (Trento) [24]. The
remaining 7 studies were carried out in other European or
non-European countries, namely, 1 in France [25], 3 in Hun-
gary [26–28], 2 in Turkey [29, 30], and 1 in Israel [31]. Overall
studied subjects were 1044 of which 582 in the experimental
groups and 462 in the control groups (by excluding patients
treated only by physical therapy and those not completing
the study, the total number of subjects evaluated in this
review is 553), although no control groupwas included in two
researches [23, 28].The total number of patients according to
the American College of Rheumatology (ACR) [10] criteria
included in each study varies considerably from 382 to 20.
Number of patients included in the experimental and control
groups and treatment characteristics is shown in Tables 1, 2,
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Table 1: Mud-bath therapy: number of patients included in the experimental and control groups.
Study Treated Patients Treatment Control Group Ongoing treatment Total Patients
Fraioli A. et al. 2011 17 Mud-bath therapy 44 yes 61
Fioravanti A. et al. 2010 40 Mud-bath therapy 40 yes 80
Fioravanti A.et al. 2011 30 Mud-bath therapy -- --- 30
Fioravanti A. et al. 2015 49 Mud-bath therapy 46 yes 95
Cantarini et al. 2007 30+24 (∘) Mud-bath therapy (∗) 20 yes (∘∘) 74
Total Patients 190 150 340
(∘) 2 experimental groups included, the first one treated by mud-bath therapy, the second one with physical therapy.
(∗) Ongoing treatment.
(∘) Not allowed any physical or pharmacological treatment during the study.
(∘∘) Not allowed glucocorticoids and intra-articular treatment with hyaluronic acid.
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Figure 1: Study Flow Diagram.
3, and 4. Four types of spa therapy were employed for patients
placed in the experimental groups: mud-bath therapy in 5
studies (Table 1) [20–24], bath therapy in 5 studies (Table 2)
[26–29, 31], mud-pack therapy in 1 study (Table 3) [30], and
spa therapy (massages, showers, mud, and pool sessions)
alone in 1 study (Table 4) [25] while patients in the control
groups were allowed to continue their ongoing therapy. Two
studies were double blinded using tap water in the control
groups [26, 27].
Even though the methods used to evaluate the results
of the therapy of the experimental groups may vary across
studies, they are generally based on quantitative evaluations.
In all studies the end points were evaluated at the beginning
and at the end of the therapy but in some studies additional
evaluation schedules were observed. Statistical analysis was
performed using common tests (Student’s t-test, Pearson’s 𝜒2
test, Wilcoxon’s test, Z value, Mann–Whitney U test, and
Friedman’s test). Instead, data from each study were critically
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Table 2: Bath therapy: number of patients included in the experimental and control groups.
Study Treated Patients Treatment Control Group Ongoing treatment Total Patients
Gaal J et al. 2008 38 Bath therapy (#) --- --- 38
Kova`cs I. et al. 2002 31 Bath therapy (∘) 27 yes 58
Tishler M., et al. 2004 48 (§) Bath therapy (#) 24 yes 72
Karagu¨lle M. et al. 2007 10 (∧) Bath therapy (#) 10 yes 20
Kulisch A et al. 2014 38 Bath therapy (##) 39 yes 77
Total Patients 165 100 265
(§) 4 patients did not complete the study.
(∧) 1 patient has not completed the study.
(∘) 2 experimental groups included, the first one treated by balneotherapy, the second one with physical therapy.
(∗) Ongoing treatment.
(#) Allowed NSAIDs treatment.
(∘) Not allowed any physical or pharmacological treatment during the study.
(##) Not allowed physical treatment and changes in ongoing NSAIDs therapy.
Table 3: Mud-pack therapy: number of patients included in the experimental and control group.
Study Treated Patients Treatment Control Group Ongoing treatment Total Patients
Odabas¸i E et al. 2009 32 Mud-pack therapy (∗∗) 25 yes 57
(∗∗) Allowed treatment with analgesic drugs in case of worsening pain, by informing the study authors.
Table 4: Spa therapy: number of patients included in the experimental and control group.
Study Treated Patients Treatment Control Group Ongoing Treatment Total Patients
Forestier R.et al. 2010 195 Multiple interventions in spa resorts 187 yes 382
analyzed and the main findings compared with those of the
other studies. For the purposes of the present review, we
reevaluated the results of the different studies using the same
statistical method, Student’s t-test, which is used to compare
themeans of two frequency distributions. Assessment of pain
was performed in all studies through Visual Analogue Scale
(VAS) [32]. Assessment of OA was performed by WOMAC
(Western Ontario and McMaster Universities Osteoarthritis
Index) [33] in 7 studies and by the Lequesne’s Index [34] in 6
studies.
The research carried out in Chianciano SPA (Siena) tested
the effects of three mud-bath therapy cycles once a day
for 12 days with sulphate-bicarbonate-calcium-magnesium
mineral water over 1 year’s time in patients with knee OA
treated with analgesics and nonsteroidal anti-inflammatory
drug (NSAID’s). The control group was only required to
continue the ongoing therapy. The patients who were already
being treated with anti-inflammatory agents and analgesics
were divided into two groups: the first group also underwent
spa therapy, and the second did not [20]. At the end of the
trial period, all patients were evaluated with VAS, Lequesne’s
Index, and the physical examination of each knee to assess the
persistence of pain at palpation and during flexion-extension
movements [32, 34].
In the second study performed in Rapolano SPA (Siena),
a 14-day mud-bath therapy cycle with bicarbonate-sulfate
mineral water was planned in the experimental group, while
ongoing therapy was allowed in experimental and control
groups. Patients were assessed at baseline time, after 2 weeks
and after 3, 6, and 9 months after the beginning of the
treatment [22]. VAS, WOMAC, and Lequesne’s Index were
used and also the Arthritis Impact Measurement Scales
(AIMS) [32–35].
Another study at Rapolano SPA (Siena) evaluated patients
with knee OA treated with a cycle of a mud-bath therapy
with sulphurous-calcium-bicarbonate mineral water. Ongo-
ing therapy was allowed. No control group was considered
in the study [23]. VAS, Lequesne’s Index, and leptin and
adiponectin plasma levels were assessed at baseline and after
2 weeks, upon completion of the mud-bath therapy [32, 34].
Another study based inChianciano SPA (Siena) evaluated
12 mud-bath therapy with sulphate-bicarbonate-calcium-
magnesium mineral water applications provided within two
weeks. Ongoing therapy was allowed in experimental and
control group [21]. Patients were assessed at basal time and
at the end of spa treatment period with VAS, WOMAC and
serum levels of adiponectin, resistin, and visfatin [32, 33].
The study at Levico SPA (Trento) evaluated patients with
knee OA and considered two experimental groups, one
of which was treated with cycle mud-bath therapy with
arsenical-ferruginous mineral water (3 weeks) and the other
with short wave therapy for the same period. Both the
experimental group and the control group patients were
allowed to continue the ongoing therapy [24]. The results
were evaluated at baseline, at the end of the treatment period,
and 12 weeks later by VAS, Lequesne’s Index, and AIMS
[32, 34, 35].
The study performed in Cserkeszo¨lo¨ Spa (Hungary) pro-
vided for the patients of the experimental group a 15-day bath
therapy cycle with sodium bicarbonate mineral water and for
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the control group a cycle of similar duration of baths with
tap water (placebo treatment) [26]. Results were evaluated at
baseline, at the end of the spa therapy, and 3months later with
VAS and symptom scores [32].
The study in Chamei Yoav SPA (Israel) evaluated the
effects of only bath therapy with salso-sulphate-bicarbonate-
calcium mineral water applied once a week for 6 consecutive
weeks. Ongoing therapy was allowed in experimental and
control groups. Evaluation was done at baseline, at weeks 4
and 6 and 4 weeks following completion of treatment (week
10) [31]. VAS, WOMAC, and Lequesne’s Index were used in
this study [32–34].
The research conducted inAlac¸ati Baths (Turkey) assessed
if patients undergoing bath therapy consisting of two
baths with sodium-chloride-sulphate-calcium-magnesium
mineral water daily (morning and afternoon) for 10 con-
secutive days were able to discontinue ongoing therapy.
Control group subjects continued ongoing pharmacological
treatment [29]. The results were evaluated at baseline, at the
end of balneotherapy, at 2weeks, and during follow-up period
at 12 and 24 weeks later by VAS and Lequesne’s Index [32, 34].
In the study from SPA He´vı´z (Hungary), baths with
sulphurous-carbonated-calcium-magnesium and very light
radon of Lake He´vı´z water were provided for 30 minutes, 5
times a week for 3 weeks in the experimental group, while the
control group patients performed the same number with the
same duration of baths with tap water (placebo treatment).
Both the experimental group and the control group patients
were allowed to continue the ongoing therapy [27]. The
research evaluated the outcome of bath therapy at baseline, at
the end of the treatment and after 15 weeks by VAS, Womac,
angle of knee flexion, joint circumference, stair-climb time,
and questionnaire of general health-related quality of life
[32, 33, 36].
The study at Bank SPA (Hungary) evaluated patients with
osteoarthritis of the knee underwent a 15-day course of bal-
neotherapy with mineral water contains sodium bicarbonate,
fluoride, and metaboric acid. The patients were allowed to
take NSAID’s or analgesic drug of their choice. No control
group was considered in the study [28]. The results were
evaluated before the start of balneotherapy and at least 2
weeks and between 10 and 14 weeks after the end of spa
treatment period by VAS, WOMAC, and the SF-36 Health
Survey [32, 33, 37].
The study in Denizli SPA (Turkey) evaluated knee OA
patients treated with mud-pack therapy rich in organic
substances (lignin and humin) for 30 minutes/day for 15 days
in 3 weeks. Patients were required to suspend any analgesic
therapy during trial except in case of intense pain. The
control group patients continued ongoing pharmacological
treatment [30]. The results were evaluated at the baseline,
after the end of spa therapy, and 30 days after the end of the
treatment by VAS,WOMAC, and the patient’s and physician’s
global assessments of disease status and response to therapy
scores [32, 33].
The study performed in three French SPAs (Aix-les-Bains,
Balaruc, and Dax) on 382 patients tested the effects of 18 spa
therapy (massages, showers, mud, and pool sessions) cycles
over three weeks (features of mineral water not indicated).
Ongoing therapy was allowed in experimental and control
groups. Follow-up was at 1, 3, and 6 months after the
beginning of the treatment [25]. The patient’s and physician’s
opinion and the Minimal Clinic Important Improvement
(MCII) were adopted for the measurement of results [38].
3. Results
The main results reported by the authors of each study are
summarized below. In the study by Fraioli et al., the parame-
ters used tomeasure the severity of the symptoms of knee OA
(VAS, Lequesne’s Index, flexion/extension, and tenderness)
were significantly reduced after 3 mud-bath therapy cycles
during 1 year; in the control group no significant differences
were observed. Even in the comparison between the patients
of the two groups that were following the therapy with drug,
the results were that, in experimental group, the percentage
of patients with no symptoms or mild symptoms was higher
than that in control group [20]. In the studies, Fioravanti
et al. observed a significant improvement of all evaluated
parameters VAS, Lequesne’s Index, W-TPS (WOMAC Total
Pain Score), W-TSS (WOMAC Total Stiffness Score), and
W-TFS (WOMAC Total Function Score) at the end of the
cycle of mud-bath therapy, whereas in the control group no
significant differences were noted [21–23]. Fioravanti et al.
found that adiponectin and resistin were reduced after mud-
bath therapy in patients with knee OA, while no decrease was
detected in the control group [21, 23].
Cantarini et al. evaluated results by VAS and Lequesne’s
Index and observed a marked improvement in the first
experimental group (mud-bath therapy) at both 3 and 12
weeks of treatment, an improvement at 3 weeks in the
second experimental group (short wave diathermy on both
knees) and a deterioration at both steps in the control group.
Also AIMS was improved in others steps. All the groups
continued ongoing therapy. The drugs dosage in the groups
varied according to pain intensity: in the first experimental
group a significant reduction in drug intake was observed
at both steps versus baseline (before starting treatment), in
the second experimental group the reduction was observed
at 3 weeks versus baseline time, and in the control group an
increase in drugs intake was observed at both 3 and 12 weeks
in comparison with baseline [24].
Kovacs et al. reported a significant amelioration of initial
pain, tenderness on palpation, walking ability, time to climb
and descend 20 steps, and patient’s and physician’s opinion in
patients treated with bath therapy and three months later this
improvement persisted only in the actively treated group.The
values reduction were significant for experimental group and
not significant for control group [26].
Moreover, Tishler et al. found that balneotherapy was
effective in improving all measuring indexes (VAS,WOMAC,
and Lequesne’s Index), except for WOMAC-Stiffness Index,
as well as a reduction in analgesic and NSAID consumption,
which was also noted in experimental group. The values
reduction were significant for experimental group and not
significant for control group, and the improvement remained
significant after 10 weeks in the experimental group [31].
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Karagu¨lle et al. by using Lequesne Algo Functional Index
(LAFI) and VAS, as well as the time taken to climb and
descend 10 steps, to make a 15-foot walk and to crouch and
raise three times observed a significant reduction in LAFI
and VAS which was found at week 2, week 12, and week 24
in the bath therapy group compared to baseline. Comparing
the two groups (experimental and control) differences, bath
therapy was superior to drug therapy in pain reduction and
in physician’s global assessment at all time points [29].
Kulish et al. evaluated results by VAS, WOMAC, right
and left knee bend angle measured with goniometer, circum-
ference of the right and left knee, time to climb 22 stairs of
the Stage Climb Time (SCT), and patient questionnaire on
quality of life in relation to health (Quality of life) observed
before, immediately after treatment, and after 15 weeks. The
obtained results were more favourable in the experimental
group than in the control group with regard to the various
parameters considered, even after 15 weeks, except for those
referring to the knee circumferences and time used for climb
the 22 steps [27].
In the study, Gaal et al. compared baselines and all
monitored parameters (VAS, WOMAC, and SF-36) were
significantly improved by balneotherapy after 2 and 14 weeks
of therapy. Moreover, patients taking NSAIDs dropped from
60.5% to 10.5% and 0% for 2 and 14 weeks of SPA treatment
[28].
Odabas¸i et al. used VAS and WOMAC scales for the
evaluation of results as well as a global health status expressed
by the patient’s and the physician’s assessment of disease
status. A significant decrease was observed in both groups
(superior in the study group as compared to the controls)
in terms of disease severity index scores. Compared to the
baseline an improvement was observed in the experimental
group in all the considered parameters 3 weeks after the
beginning of the study, and a greater improvement was
observed 7 weeks after the beginning of the study. The
number of patients who had MCII was significantly higher
in the study group at week 3 and remained high till the end of
the follow-up period [30].
Finally Forestier et al. reported that a three-week period
of spa treatment combined with a pharmacologic and home
exercise program was superior to conventional treatments
and exercise alone at the end of sixth month, and it was
better tolerated. The author found that the percentage of
patients who reached theMCII was significantly higher in the
experimental group than in the control group, 50,8% versus
36,4%, and a significant reduction of VAS and WOMAC
was observed after 6 months from the end of treatment.
The overall opinions of the patient (SF36 scores) and the
examining physician at 6 months showed an improvement in
both groups (54.4%) [25].
4. Discussion
Therapy of knee osteoarthritis is based on pharmacological
and nonpharmacological measures. These include the use
of SPA therapy (comprises a broad spectrum of therapeutic
modalities including hydrotherapy, balneotherapy,mud-pack
therapy, mud-bath therapy, massage, and exercise) to supple-
ment or alternate pharmacological and/or physiotherapeutic
therapy, with favourable results on pain, drug use, and
improving the patient’s general well-being. The biological
effects of mud-bath therapy in osteoarthritis are mainly
secondary to thermal and chemical stimuli. The thermal
effects are characterized by an increase in the temperature of
the skin, subcutaneous tissue, and muscles, with decreasing
muscular tone. Hyperaemia at periarticular sites (capsules,
ligaments, and tendon insertions) caused by heat stimu-
lation of the thermal mud can contribute to the removal
of inflammatory cytokines and chemokines thus reducing
pain [19, 39]. The heat component plays a fundamental
role together with the organic and inorganic properties of
the thermal medium (mineral content) [40, 41]. Numerous
studies have highlighted the effects ofmud-pack therapy, bath
therapy, or mud-bath therapy on prostaglandin E2 (PGE2),
leukotriene B4 (LTB4), tumor necrosis factor-alpha (TNF-
𝛼), interleukin-1𝛽 (IL-1𝛽), interleukin-6 (IL-6), metallopro-
teinases (MMP-3), prolactin and growth hormone (GH),
insulin-like growth factor I (IGF1), transforming growth
factor beta (TGF-𝛽), reactive oxygen species (ROS), cata-
lase, malondialdehyde (MDA), superoxide dismutase (SOD)
and glutathione peroxidase (GSH-peroxidase), nitric oxide
(NO) and myeloperoxidase (MPO), adiponectin, cartilage
oligomeric matrix protein (sCOMP), and systemic modifi-
cation of the chondrocyte markers, suggesting a protective
action on articular cartilage [42–48]. The general effect of
mud-bath therapy with thermal waters is achieved through
influences on the hypothalamus-pituitary-adrenal axis, with
increased secretion of Adreno Cortico Tropic Hormone
(ACTH) and cortisol and greater production of endogenous
opioids (𝛽-endorphin) [49, 50].
Some systematic reviews on spa therapy for kneeOAhave
recently been published [51–55].
Because the studies we reviewed differed markedly from
one another in terms of the methods used, we were unable
to conduct a quantitative analysis (meta-analysis) of pooled
data from the 12 studies. We finally summarized the results
obtained from the literature on the basis of the main out-
comes of the different studies included in this review. The
results of SPA therapy according tomeasures employed in the
studies evaluated are shown in Table 5.
Concerning the VAS, 297 patients were homogeneously
evaluated among 12 studies.Themean VAS values before and
after SPA therapy were 54.71 and 29.36, respectively, showing
a significant reduction corresponding to 46.34% if compared
with the initial value (Table 5-line 1).
With regard to Lequesne’s Index, it was used in 6 of the
studies included in this review over a total of 140 patients in
the SPA treated groups [20, 22–24, 29, 31]. Mean Lequesne’s
Index significantly improved with an overall improvement of
33.78% compared to the initial value (Table 5-Line 2).
The WOMAC was evaluated in 7 studies. WOMAC
includes three different measurement scales: WOMAC Total
Pain Score (TPS), WOMAC Total Stiffness Score (TSS), and
WOMACTotal Physical Function Score (TPFS). Four studies
[21, 22, 27, 31] evaluated results from all the three WOMAC
scales; in other two researches [25, 28] only the third version
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Table 5: Results of SPA therapy according to measures employed in the studies evaluated.
Measure scales applied Number of patients (1) Mean values b1- b2 Reduction % (2)
b1 before treatment b2 after treatment
VAS 297 54.71 29.36 - 25.35 - 46.34
Lequesne’s Index 140 56.61 37.49 - 19.12 - 33.78
WOMAC – TPS (3) 170 21.49 13.74 - 7.75 - 36.06
WOMAC – TSS (4) 126 27.78 16.98 - 10.80 - 38.87
WOMAC – TPFS (5) 387 40.26 26.71 - 13.55 - 33.65
(1) Number of patients included in the experimental groups participating in the studies using a specific measure scale, excluding the studies in which data are
expressed differently from practice (for instance, with percentage but without absolute values, only with a graphic representation, etc.).
(2) Calculated according to the following procedure: values at the treatment end if the starting values are = 100 (referring to VAS) 29,36:54,71 = x:100; x = 53,66
= value observed at the end of treatment if starting value is 100; 100-53,66 = 46,34 = percentage reduction of VAS value at the treatment end.
(3) TPS =Total Pain Score.
(4) TSS =Total Stiffness Score.
(5) TPFS =Total Physical Function Score.
(W-TPFS) was measured; finally, in the last study [30] a
global index was derived from the sum of scores of the three
WOMAC scales. WOMAC Total Pain Score was examined
in 4 studies, for a total of 170 patients [21, 22, 27, 31].
WOMAC improved before and after SPA therapy from 21.49
to 13.74, respectively, suggesting a decrease in pain of 36.06%
(considering the initial value = 100) (Table 5-line 3).
Similarly, the results evaluated with the WOMAC Total
Stiffness Score (total patients =126), were equally favourable.
In fact, the mean values of the index calculated on the total
of patients before and after the treatment were 27.78 and
16.98, respectively. Hence, WOMAC was reduced by 38.87%
(Table 5-line 4). Finally, the third WOMAC scale (WOMAC
Total Physical Function Score) was investigated in 6 studies
[21, 22, 25, 27, 28, 31]. The total number of patients for the
evaluation was 387; the mean scores were 40.26 and 26.71
before and after therapy, respectively. Thus, reduction was
33.65% from the initial WOMAC value (Table 5-line 5).
AIMS was evaluated in 2 studies [22, 24] and SF36 in
other 2 studies [25, 28]. AIMS was improved in all studies
suggesting that psychological aspects, such as anxiety and
depression, can also be positively influenced by SPA therapy.
SF36 also improved in all considered studies. Two studies
evaluated adipokines, specifically adiponectin, resistin, and
visfatin, showing that adiponectin and resistin can be reduced
by mud-bath therapy [21, 23].
5. Conclusions
To conclude, SPA therapy on the ground of the researches
objective of this review is effective in the management of
knee OA and significantly improves the pain and functional
status of patients with knee OA. SPA therapy is a noninvasive,
complication-free, and cost-effective alternative modality for
the conservative treatment of knee osteoarthritis.
The mud-pack therapy, bath therapy, mud-bath therapy,
and SPA therapy have proved to be effective in the treatment
and in preventing progression of the disease and the onset
of disability (secondary prevention) of knee osteoarthritis,
by reducing pain and functional limitation and improving
quality of life of affected patients. Turkish League against
Rheumatism states that balneotherapymay be recommended
for at least two weeks of treatment because of its ther-
mal and nonthermal effects. In addition to this treatment,
peloidotherapy may be advised [56]. In the OARSI guide-
lines for the nonsurgical management of knee osteoarthritis,
balneotherapy was considered appropriate only for the sub-
phenotype with multiple-joint OA (symptomatic OA of the
knee) in addition to other joints (e.g., hip, hand, and spine)
and comorbidities (diabetes, hypertension, cardiovascular
disease, renal failure, gastrointestinal bleeding, depression,
physical impairment limiting activity, and obesity) due to
paucity of treatment alternatives for that group [57]. Indica-
tions based on the clinical guidelines of the French National
Authority suggest that patients with knee osteoarthritismight
gain the benefit of a persistent improvement (at least twelve
weeks) of pain, analgesic and nonsteroidal anti-inflammatory
drug consumption, functional capacity, and/or quality of life
[58].
RCTs findings suggest that spa therapy is part of an inte-
grated and synergistic multidisciplinary approach with other
treatments (pharmacotherapy, physiotherapy), allowing also
the reduction of conventional treatment dosage, possibly
resulting in lesser costs and drug-related adverse events, and
further improving the quality of life of affected patients.
Moreover, patients benefit from staying in an environment
with a favorable and relaxing climate with a positive impact
on their perception of wellbeing [59].
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